Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Browse by collection
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Browse by collection
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Indoleamine 2,3-dioxygenase
Email alerts
Indoleamine 2,3-dioxygenase
Tryptophan potentiates CD8
+
T cells against cancer cells by TRIP12 tryptophanylation and surface PD-1 downregulation
Rui
Qin
,
Chen
Zhao
,
Chen-Ji
Wang
,
Wei
Xu
,
Jian-Yuan
Zhao
,
Yan
Lin
,
Yi-Yuan
Yuan
,
Peng-Cheng
Lin
,
Yao
Li
,
Shimin
Zhao
,
Yan
Huang
Journal for ImmunoTherapy of Cancer
Jul 2021,
9
(7)
e002840;
DOI:
10.1136/jitc-2021-002840
Targeting the indoleamine 2,3-dioxygenase pathway in cancer
Yong Wha
Moon
,
Joud
Hajjar
,
Patrick
Hwu
,
Aung
Naing
Journal for ImmunoTherapy of Cancer
Dec 2015,
3
(1)
51;
DOI:
10.1186/s40425-015-0094-9
Special collections
COVID-19
(44)
Editor's choice
JITC
Basic Tumor Immunology
(538)
Case Reports
(191)
Clinical Trials Monitor
(17)
Clinical/Translational Cancer Immunotherapy
(940)
Commentary/Editorials
(142)
Computational I-O
(4)
COVID-19 and Cancer Immunotherapy
(10)
Emerging Immunotherapeutic Agents
(5)
Guidelines and Consensus Statements
(54)
Guidelines and Consensus Statements
(50)
Imaging and Immunotherapy
(8)
Immune Cell Therapies and Immune Cell Engineering
(213)
Immune Checkpoints - Beyond PD-1
(8)
Immune Checkpoints Beyond PD-1 Series
(8)
Immune Monitoring Technology Primers
(12)
Immunotherapy Biomarkers
(405)
Liquid Biopsies
(9)
Microbial-Based Cancer Immunotherapy
(4)
Oncolytic and Local Immunotherapy
(143)
Reviews
(239)
Open access
(4867)
Press releases
